Published in Mayo Clin Proc on February 01, 1983
Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother (1989) 5.28
Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev (1990) 3.82
Vancomycin-resistant streptococci or Leuconostoc sp. Antimicrob Agents Chemother (1985) 3.57
Infection caused by vancomycin-resistant Streptococcus sanguis II. Antimicrob Agents Chemother (1984) 2.66
Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228. Antimicrob Agents Chemother (1990) 2.50
Pharmacokinetics of vancomycin in patients with various degrees of renal function. Antimicrob Agents Chemother (1984) 2.09
Comparison of steady-state pharmacokinetics of two dosage regimens of vancomycin in normal volunteers. Antimicrob Agents Chemother (1987) 1.86
Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrob Agents Chemother (1993) 1.34
Laboratory evaluation of five assay methods for vancomycin: bioassay, high-pressure liquid chromatography, fluorescence polarization immunoassay, radioimmunoassay, and fluorescence immunoassay. J Clin Microbiol (1984) 1.33
Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother (1992) 1.32
Vancomycin enhancement of experimental tobramycin nephrotoxicity. Antimicrob Agents Chemother (1986) 1.24
Accuracy of the KOH and vancomycin tests in determining the Gram reaction of non-enterobacterial rods. J Clin Microbiol (1983) 1.16
Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Antimicrob Agents Chemother (1997) 1.14
Impaired target site penetration of vancomycin in diabetic patients following cardiac surgery. Antimicrob Agents Chemother (2006) 1.00
Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis. Antimicrob Agents Chemother (1984) 0.99
Determination of vancomycin in human serum by high-pressure liquid chromatography. Antimicrob Agents Chemother (1985) 0.97
Concentrations of vancomycin in bone and serum of normal rabbits and those with osteomyelitis. Antimicrob Agents Chemother (1984) 0.95
Persistent staphylococcal bacteremia in an intravenous drug abuser. Antimicrob Agents Chemother (1986) 0.94
Sustained release of antibiotics from injectable and thermally responsive polypeptide depots. J Biomed Mater Res B Appl Biomater (2009) 0.83
Exfoliative reaction to vancomycin. Br Med J (Clin Res Ed) (1988) 0.75
Future prospects and therapeutic potential of streptogramins. Drugs (1996) 0.75
Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest (1976) 3.65
Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients. Am J Med (1976) 3.36
Antibiotics synergism: enhanced susceptibility of group D streptococci to certain antibiotic combinations. Antimicrob Agents Chemother (Bethesda) (1970) 3.05
Coryneform bacterial endocarditis: difficulties in diagnosis and treatment, presentation of three cases, and review of literature. Mayo Clin Proc (1977) 2.63
Polymicrobial bacteremia. Ann Intern Med (1970) 2.40
Infections due to group C streptococci in man. Am J Med (1979) 2.08
Musculoskeletal manifestations of bacterial endocarditis. Ann Intern Med (1977) 2.04
Group G streptococcal bacteremia: clinical study and review of the literature. Rev Infect Dis (1983) 2.00
Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93
Streptococcus mutans endocarditis. Ann Intern Med (1974) 1.86
Endocarditis caused by coagulase-negative staphylococci. Mayo Clin Proc (1968) 1.84
Prosthetic valve endocarditis. Ann Intern Med (1975) 1.78
Dysgammaglobulinemia associated with nodular lymphoid hyperplasia of the small intestine. Am J Med (1966) 1.74
Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis. Ann Intern Med (1984) 1.64
Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc (1982) 1.57
In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53
Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52
Eikenella corrodens endocarditis: report of cure in two cases. Mayo Clin Proc (1974) 1.52
Vancomycin. Mayo Clin Proc (1977) 1.50
Quality-of-care assessment. I. Outpatient management of acute bacterial cystitis as the model. Mayo Clin Proc (1976) 1.45
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci. Antimicrob Agents Chemother (1982) 1.41
Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin. JAMA (1981) 1.39
Prosthetic valve endocarditis. Mayo Clin Proc (1982) 1.36
Haemophilus endocarditis. Report of 14 patients. Mayo Clin Proc (1977) 1.35
Neurologic manifestations of bacterial endocarditis. Ann Intern Med (1969) 1.33
Vancomycin therapy for infective endocarditis. Rev Infect Dis (1982) 1.30
Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis. Antimicrob Agents Chemother (1980) 1.29
Treatment of streptococcal infective endocarditis. Am J Med (1985) 1.28
Pulmonary manifestations of hypogammaglobulinaemia. Thorax (1978) 1.25
Fatal Vibrio fetus endocarditis: report of one case and review of the literature. Virchows Arch A Pathol Pathol Anat (1970) 1.24
In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother (1987) 1.23
The first 100 liver transplantations at the Mayo Clinic. Mayo Clin Proc (1989) 1.22
Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis (1989) 1.19
Meningitis due to group C streptococci in an adult. Mayo Clin Proc (1978) 1.17
Infective endocarditis--a 25 year overview of diagnosis and therapy. J Am Coll Cardiol (1983) 1.16
Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1983) 1.14
Anticoagulant therapy and central nervous system complications in patients with prosthetic valve endocarditis. Circulation (1978) 1.14
Cryptococcosis, with emphasis on the significance of isolation of Cryptococcus neoformans from the respiratory tract. Chest (1977) 1.11
Postoperative prosthetic valve bacterial endocarditis due to Corynebacterium xerosis. Mayo Clin Proc (1967) 1.11
Life-threatening soft-tissue infections of the neck. Laryngoscope (1984) 1.10
The clinical manifestations of infective endocarditis. Mayo Clin Proc (1982) 1.06
Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation (1988) 1.06
Immune deficiency diseases. Postgrad Med (1973) 1.06
Management of complications of infective endocarditis. Mayo Clin Proc (1982) 1.06
Group B streptococcal infective endocarditis. Arch Intern Med (1985) 1.06
Infective endocarditis caused by Actinobacillus actinomycetemcomitans: report of four cases. Mayo Clin Proc (1980) 1.03
Antibiotic treatment of infective endocarditis. Annu Rev Med (1983) 1.02
Mollaret's meningitis and differential diagnosis of recurrent meningitis. Report of case, with review of the literature. Am J Med (1972) 1.01
Empiric therapy with moxalactam alone in patients with bacteremia. Mayo Clin Proc (1984) 1.00
Diagnosis of nocardiosis by blood culture. Mayo Clin Proc (1974) 0.95
Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation (1988) 0.94
Laboratory and clinical evaluation of cephaloridine, a cephalosporin derivative. Antimicrob Agents Chemother (Bethesda) (1965) 0.94
Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis. Antimicrob Agents Chemother (1982) 0.94
Antimicrobial therapy of experimental endocarditis caused by nutritionally variant viridans group streptococci. Antimicrob Agents Chemother (1986) 0.94
Short-term intramuscular therapy with procaine penicillin plus streptomycin for infective endocarditis due to viridans streptococci. Circulation (1978) 0.93
Treatment of penicillin-sensitive streptococcal infective endocarditis. Mayo Clin Proc (1982) 0.93
Beta-hemolytic group F streptococcal bacteremia: a study and review of the literature. Rev Infect Dis (1985) 0.92
Rapid shell vial culture and tissue histology compared with serology for the rapid diagnosis of cytomegalovirus infection in liver transplantation. Mayo Clin Proc (1989) 0.92
Treatment of fungal infections with flucytosine. Arch Intern Med (1975) 0.92
Nodular lymphoid hyperplasia of the small intestine and hypogammaglobulinemia: theoretical and practical considerations. Fed Proc (1968) 0.91
Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. J Hepatol (1993) 0.90
Treatment of streptomycin-susceptible enterococcal experimental endocarditis with combinations of penicillin and low- or high-dose streptomycin. Antimicrob Agents Chemother (1986) 0.89
Idiopathic granulomatosis manifesting as fever of unknown origin. Mayo Clin Proc (1989) 0.89
Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Transplant Proc (1987) 0.88
Endogenous Candida oculomycosis. Report of two patients treated with flucytosine. Arch Ophthalmol (1974) 0.88
Cardiobacterium hominis endocarditis. Four cases with clinical and laboratory observations. Mayo Clin Proc (1978) 0.88
Valve replacement in patients with active infective endocarditis. Circulation (1978) 0.87
Pancreatitis complicating typhoid fever. Report of a case. JAMA (1976) 0.87
Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc (1987) 0.86
Activity of penicillin combined with an aminoglycoside against group B streptococci in vitro and in experimental endocarditis. J Antimicrob Chemother (1986) 0.84
Bacterial infections after liver transplantation. Eur J Clin Microbiol Infect Dis (1989) 0.84
Synergy of imipenem or penicillin G and aminoglycosides against enterococci isolated from patients with infective endocarditis. Antimicrob Agents Chemother (1984) 0.83
Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc (1977) 0.83
Gastrointestinal dysfunction in immunoglobulin deficiency. Effect of corticosteroids and tetracycline. JAMA (1975) 0.82
Abnormal chemotaxis in patients with cutaneous anergy. Mayo Clin Proc (1977) 0.82
Bactericidal activity of combinations of penicillin or clindamycin with gentamicin or streptomycin against species of viridans streptococci. Antimicrob Agents Chemother (1975) 0.82
Cardiac valve replacement in congestive heart failure due to infective endocarditis. Mayo Clin Proc (1979) 0.82
Repeatedly relapsing disseminated histoplasmosis: clinical observations during long-term follow-up. J Infect Dis (1987) 0.81
General principles of antimicrobial therapy. Mayo Clin Proc (1977) 0.81
Pneumocephalus due to barotrauma: CT demonstration. AJR Am J Roentgenol (1992) 0.79
Antimicrobial agents in the treatment of obstetric and gynecologic infections. Med Clin North Am (1974) 0.79
Hypohaptoglobinemia and valvular heart disease: association with hemolysis after insertion of valvular prostheses and in cases in which operation had not been performed. Mayo Clin Proc (1966) 0.79
Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: role of immunostaining, DNA hybridization and culture of hepatic tissue. Hepatology (1990) 0.79
Cardiac valve replacement in patients with active infective endocarditis. Herz (1983) 0.78
Association of gastric carcinoma with idiopathic late-onset immunoglobulin deficiency. Ann Intern Med (1972) 0.78
Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc (1983) 0.78
Serum antibody activity in patients with histoplasmosis as measured by passive hemagglutination. J Lab Clin Med (1969) 0.78
In vitro and in vivo studies of streptomycin-resistant, penicillin-susceptible streptococci from patients with infective endocarditis. J Infect Dis (1987) 0.77
Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation. Hepatology (1992) 0.77
Endocarditis due to a rapidly growing chromogenic Mycobacterium. Mayo Clin Proc (1968) 0.77
Cephalexin: preliminary in vitro studies of a new orally administered cephalosporin and report of a case of endocarditis cured with cephalexin. Mayo Clin Proc (1969) 0.76
Antiviral agents. Mayo Clin Proc (1983) 0.75
General considerations in the diagnosis and treatment of infective endocarditis. Mayo Clin Proc (1982) 0.75
Wiskott-Aldrich syndrome in an adult. Mayo Clin Proc (1974) 0.75
Immunologic deficiency syndromes. S D J Med (1972) 0.75
Results of surgical and nonoperative treatment for pulmonary North American blastomycosis. J Thorac Cardiovasc Surg (1966) 0.75
Massive diffuse hypergammaglobulinemia. Its diagnostic significance. Minn Med (1969) 0.75